A detailed history of Crews Bank & Trust transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Crews Bank & Trust holds 6,526 shares of BMY stock, worth $283,163. This represents 0.05% of its overall portfolio holdings.

Number of Shares
6,526
Previous 5,391 21.05%
Holding current value
$283,163
Previous $329 Million 8.12%
% of portfolio
0.05%
Previous 0.06%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 21, 2025

BUY
$44.12 - $59.6 $50,076 - $67,646
1,135 Added 21.05%
6,526 $302 Million
Q1 2025

Apr 22, 2025

SELL
$53.9 - $63.11 $28,620 - $33,511
-531 Reduced 8.97%
5,391 $329 Million
Q4 2024

Jan 23, 2025

BUY
$51.92 - $59.94 $307,470 - $354,964
5,922 New
5,922 $335 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $92.3B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Crews Bank & Trust Portfolio

Follow Crews Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crews Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Crews Bank & Trust with notifications on news.